When Should You Worry About West Nile Symptoms?
Worry when a fever or bad headache in the two weeks after a mosquito bite comes with something neurologic: confusion, a stiff neck, tremor, new weakness, trouble walking, a drooping face. Most West Nile infections cause nothing at all, and most of the rest are a self-limited flu-like illness. The dangerous share announces itself through the nervous system, and it has worse odds in older adults, people with weakened immunity, and those with major chronic conditions.
The odds after a bite are heavily in your favor. About 70 to 80 percent of West Nile infections cause no symptoms at all. Another fifth bring West Nile fever, a self-limited run of fever, headache, muscle aches, fatigue, and sometimes a rash. Fewer than 1 percent reach the nervous system. So the job after a bite is narrow: separate that rare serious case from the common mild one, and the thing that separates them is neurologic.
The two-week clock after a bite
If symptoms come, they usually show up 2 to 6 days after the bite, but they can start any time from 2 to 14 days. The window can run longer if your immune system is weak. Blood-donor data from a large Italian outbreak fit this: donors who tested positive while still symptom-free and later fell ill got sick 1 to 10 days after donating. Donation isn't the bite, but it captures the short gap from virus in the blood to illness. For most people, if two weeks pass after a concerning bite with nothing, West Nile is unlikely to be your problem.
The signs that change the calculation
Fever alone won't tell you which illness you have; it runs through both. What matters is what the fever brings with it. In neuroinvasive cases the standouts are confusion or altered mental status, focal weakness, and acute flaccid paralysis. That can look like sudden polio-like limb weakness after damage to nerve cells in the spinal cord, and it can be permanent. Others carry the same urgency: a stiff neck, tremor or twitching, a drooping face or other cranial-nerve weakness, unsteadiness, and, at the worst end, coma. Any one of these on top of fever moves you from watchful waiting to prompt evaluation.
| Situation | What the evidence suggests | What it means for you |
|---|---|---|
| No symptoms after 14 days | West Nile becomes unlikely for most people, though the window can run longer in immunocompromised people | No WNV-specific action if otherwise well; keep preventing bites |
| Fever, headache, body aches, fatigue, or rash, with no neurologic signs | If it is West Nile, this fits the common, self-limited West Nile fever pattern | Rest, fluids, and acetaminophen are reasonable; contact a healthcare provider about testing if West Nile is plausible |
| Fever or severe headache plus confusion, stiff neck, tremor, new weakness, trouble walking, facial weakness, or paralysis | Possible neuroinvasive disease | Seek urgent medical evaluation without waiting |
| Any concerning symptoms in an older, immunosuppressed, or medically high-risk person | Higher chance of severe disease and worse outcomes | Lower your threshold and get evaluated sooner |
Who should move faster
Age is the strongest and most consistent driver of severe disease. Both the risk of neuroinvasive disease and the risk of dying from it climb steeply with age: US surveillance put neuroinvasive case fatality around 2 percent under 50 and roughly 21 percent at 70 and older. Immunosuppression is the other heavyweight. In one cohort, neuroinvasive disease killed about 28 percent of immunosuppressed patients within 90 days versus about 7 percent of others, and they more often ended up in the ICU. Among the most immunosuppressed, people with blood cancers, transplants, or B-cell-depleting therapy, reported mortality has run higher still. Chronic kidney disease is one of the strongest markers of a fatal course, and diabetes and hypertension have been tied to worse outcomes too. A mild, non-neurologic illness may be reasonable to monitor in a healthy 35-year-old; in these groups, set the bar for getting evaluated lower. Neuroinvasive disease overall kills about 1 in 10, and among survivors, fatigue, memory trouble, weakness, and tremor often linger for months.
Why there's no pill to reach for
There's no approved antiviral, no licensed human vaccine, and no proven targeted treatment for West Nile. Care is supportive: fluids, fever and headache control, and in severe cases hospital support for breathing, seizures, and pressure in the brain. Targeted therapies people ask about have not shown a clear clinical benefit. A randomized trial of high-titer West Nile immunoglobulin in hospitalized patients with neuroinvasive disease found no clear benefit over standard immunoglobulin or saline. Corticosteroids haven't helped and may harm: one small multicenter retrospective study found no drop in death or neurological problems at discharge, and another retrospective cohort tied early steroids to higher hospital mortality. Timing is part of the problem. By the time neurologic disease is recognized, treatment often starts days in, and trials are hard to run because outbreaks are unpredictable and the window is narrow.
For mild illness, the CDC's advice is acetaminophen, fluids, and rest, with one specific trap to avoid: skip ibuprofen and other NSAIDs if you're somewhere dengue also circulates, because dengue can resemble West Nile early and NSAIDs are riskier in dengue. If West Nile seems plausible given your symptoms and the season, talk with a healthcare provider about WNV-specific IgM testing. It usually becomes detectable 3 to 8 days after illness starts, so a very early negative may need repeating.
Most West Nile infections never become serious, so a mild fever after a bite rarely deserves alarm. But fever plus any neurologic change, or worrying symptoms in someone older, immunocompromised, or medically vulnerable, is when waiting stops making sense. What would change this is a treatment that works once illness is recognized, or exposure studies sharp enough to predict early who will progress. Neither exists yet.